CSI Market
Sign In | Register

Greenway Medical Technologies Inc (GWAY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GWAY Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Greenway Medical Technologies Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2013)
3 Months 		(Mar 31 2013) (Dec 31 2012) (Sep 30 2012) (Jun 30 2012)
Operating Activities
Income-4.82
Depreciation & amortization2.95
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.74
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.29
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.06
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Reversal Of Deferred Tax Valuation Allowance-
Income taxes-1.80
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-1.15
Increase (Decrease) in Accounts Payable and Accrued Liabilities6.19
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.36
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities1.64
Investing Activities
Capital Expenditures-5.65
Sale of Capital Items0.00
Payments to Acquire Short-term Investments6.74
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Technology And Other Intangibles-
Payment To Acquire Technology And Other Asset-
Payments To Acquire Business And Developed Technology-6.75
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities1.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.29
Payments On Obligation For Acquired Technology-0.12
Proceeds From Exercise Of Stock Options And Warrantsnet Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.29
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.01
Total Cash Flow3.01
4 historic quarters locked

Sign in to unlock the full Greenway Medical Technologies Inc cash flow history.

Sign In Create Free Account

About GWAY Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.